STOCK TITAN

Elkhart Clinic Joins American Oncology Network, Becomes Elkhart Hematology and Oncology

(Very Positive)
Tags

Elkhart Hematology and Oncology (formerly Elkhart Clinic’s hematology and oncology practice) joined American Oncology Network (AONC) on May 5, 2026, expanding patient access to clinical trials and community-based cancer care. The practice will continue onsite infusion, centralized lab/pathology, specialty pharmacy, care coordination and financial counseling.

Dr. Ahsanul Haque and Charisse Prall, FNP-BC will continue to lead clinical services and are accepting new patients.

Loading...
Loading translation...

Positive

  • Expanded clinical trials access for local patients through AON network
  • Onsite infusion and specialty pharmacy retained for patient convenience
  • Centralized lab and pathology services maintained to support care
  • Care coordination and financial counseling preserved to assist patients
  • Practice leadership (Dr. Haque and Charisse Prall) continuing and accepting new patients

Negative

  • None.

Market Context

This announcement adds another community-based oncology and hematology practice to American Oncology...
Analysis

This announcement adds another community-based oncology and hematology practice to American Oncology Network’s footprint, reinforcing its focus on local access, infusion services, and clinical trial availability. Recent history shows a steady stream of partnerships and physician additions across multiple states. Investors following this story may watch for continued practice integrations, operational execution at new sites, and how expanded services translate into sustainable network-wide performance over time.

Key Figures

Publication date: May 05, 2026
1 metrics
Publication date May 05, 2026 Press release announcement date

Historical Context

5 past events · Latest: Apr 30 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 30 Physician addition Positive +2.8% New board-certified oncologist joined MidAmerica Cancer Care under AONC.
Apr 22 Conference participation Positive +16.1% AON leaders presenting 11 sessions at major oncology conference.
Mar 05 Practice acquisition Positive -7.3% Oncology Consultants joined AON, expanding South Texas footprint.
Feb 04 Practice partnership Positive +4.3% RKV Medical Center became AON’s first partner practice in Oklahoma.
Feb 03 Physician addition Positive +4.3% Dr. Amy Braden joined Hematology Oncology of Indiana within AON.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Practice expansion and physician-affiliation news has generally seen positive next-day reactions, with one notable negative divergence.

Recent Company History

Over the past few months, American Oncology Network has repeatedly highlighted growth in community oncology. Partnerships like Oncology Consultants joining AON, RKV Medical Center becoming its first Oklahoma partner, and new physicians such as Dr. Amy Braden and Dr. Syed Karim have expanded geographic reach and clinical depth. Market reactions were mostly positive, with moves of +4.35%, +4.35%, and +2.78%, and a stronger +16.13% gain around conference participation, offset by a -7.33% drop on another expansion headline. Today’s Elkhart clinic affiliation continues this growth-focused pattern.

Key Terms

hematology, oncology, clinical trials, infusion therapy, +2 more
6 terms
hematology medical
"Elkhart Clinic’s hematology and oncology practice has joined American Oncology Network"
Hematology is the branch of medicine that studies blood, its components (like red and white cells and platelets), and disorders that affect them. For investors, it matters because treatments, diagnostics, and devices that diagnose or fix blood problems can drive sales, regulatory risk, and patent value—think of it as investments in the maintenance and repair of the body's delivery system, where breakthroughs or setbacks can quickly change a company's prospects.
oncology medical
"Elkhart Clinic’s hematology and oncology practice has joined American Oncology Network"
Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.
clinical trials medical
"expand patient-focused services, enhance access to clinical trials and pursue new growth"
Clinical trials are carefully controlled studies that test whether a new drug, device or treatment is safe and effective in people, moving through successive stages that increase the number of participants and the rigor of testing. Investors care because trial outcomes determine whether a product can be approved and sold, shaping a company’s future revenue, valuation and risk profile—think of it as proof-of-concept testing that decides if a prototype becomes a market-ready product.
infusion therapy medical
"Services include onsite infusion therapy, centralized laboratory and pathology services"
Infusion therapy is the delivery of medicines, nutrients or fluids directly into a vein or body cavity over a set time using an IV line, pump or catheter, like a slow, controlled drip that bypasses swallowing. Investors care because it underpins durable healthcare revenue streams—hospital and home-based services, specialized equipment and drug sales—while regulatory approvals, safety issues and reimbursement rules can affect demand and margins.
pathology medical
"onsite infusion therapy, centralized laboratory and pathology services"
Pathology is the medical study and lab testing of disease, usually involving examination of tissue, blood, or other samples to determine what is wrong and why. For investors, pathology findings act like a forensic report for a drug, device, or diagnostic: they can confirm whether a treatment works, reveal safety issues, influence regulatory approval and market demand, and therefore affect a health‑care company’s prospects and valuation.
specialty pharmacy medical
"an in-house specialty pharmacy, comprehensive care coordination and dedicated financial"
A specialty pharmacy is a pharmacy that focuses on dispensing and managing high-cost, complex medications that often need special storage, handling, administration or ongoing patient monitoring—think of it as a concierge service for drugs that require extra care. Investors pay attention because these pharmacies control access, support adherence and billing for expensive treatments, which affects drug sales, reimbursement, margins and long-term revenue predictability for manufacturers and payers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ELKHART, Ind., May 05, 2026 (GLOBE NEWSWIRE) -- Elkhart Clinic’s hematology and oncology practice has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices. The practice, located at 2117 W. Lexington Ave., will now be known as Elkhart Hematology and Oncology.

This partnership enables Ahsanul Haque, MD, and Charisse Prall, FNP-BC, to expand patient-focused services, enhance access to clinical trials and pursue new growth opportunities while continuing to deliver the high-quality, compassionate care that has defined the practice since its founding.

13770_EHO_Haque-Prall_Press-Release_Headshot_260501_FINAL (3)

Dr. Haque is a Board-certified medical oncologist and hematologist who earned his medical degree from Dow Medical College. He completed his residency and fellowship training in hematology and oncology at Maimonides Medical Center in Brooklyn, New York, where he developed expertise in both malignant and benign hematologic conditions, as well as solid tumor oncology.

Prall is a Board-certified family nurse practitioner who earned her Master of Science in nursing, with a family nurse practitioner specialty, from the University of Saint Francis. Her experience in oncology and hematology includes providing comprehensive care to patients with solid tumors, hematologic malignancies and nonmalignant hematologic conditions.

“We are pleased to join American Oncology Network,” said Dr. Haque. “The organization shares our commitment to delivering exceptional, research-based cancer care. This partnership strengthens our ability to support our patients as whole people – physically, emotionally, and financially. Together, we are well-positioned to provide a compassionate, patient-centered experience for every individual we serve.”

Elkhart Hematology and Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. The practice offers comprehensive cancer care, combining the expertise of a cancer specialty practice with the accessibility of care close to home. Services include onsite infusion therapy, centralized laboratory and pathology services, an in-house specialty pharmacy, comprehensive care coordination and dedicated financial counseling.

“We are thrilled to welcome Elkhart Hematology and Oncology to American Oncology Network,” said Todd Schonherz, chief executive officer of AON. “Dr. Haque and Charisse’s dedication to delivering exceptional, patient-centered care in Indiana aligns with AON’s mission to expand access to high-quality, community-based oncology services across the nation, and we couldn’t be happier that they’ve decided to join us.”

“Dr. Haque and Charisse have built an exceptional community oncology practice in Elkhart,” said Stephen “Fred” Divers, MD, chief medical officer of AON. “We are looking forward to partnering with them to continue delivering compassionate, patient-centered care in Indiana, and benefiting from their clinical expertise and commitment across the network.”

Dr. Haque is accepting new patients. To learn more about Elkhart Hematology and Oncology, visit elkharthemonc.com. For more information about American Oncology Network, visit AONcology.com.

About Elkhart Hematology and Oncology
Elkhart Hematology and Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best possible experience to patients and their families throughout the healthcare journey.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com more information, or follow us on LinkedInFacebookX (formerly Twitter) and YouTube.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/59398b11-cbed-49db-8fbc-47a6d81eafa4



Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

FAQ

What does Elkhart Hematology and Oncology joining AONC mean for patients?

Patients gain broader access to clinical trials and network resources through AONC. According to American Oncology Network, the partnership enables expanded research options, maintained onsite infusion, centralized lab/pathology, specialty pharmacy, care coordination and financial counseling at the Elkhart location.

Who will lead the Elkhart Hematology and Oncology practice after the AONC partnership?

The practice will continue under Dr. Ahsanul Haque and Charisse Prall as clinical leaders. According to American Oncology Network, both clinicians will expand patient-focused services and maintain the practice’s local cancer and blood disorder care.

Is Elkhart Hematology and Oncology accepting new patients after joining AONC (AONC)?

Yes, Dr. Haque is accepting new patients at the Elkhart clinic following the partnership. According to American Oncology Network, the practice continues to provide community-based oncology care with onsite infusion and comprehensive support services.

What clinical services will remain available at the Elkhart location after joining AONC (AONC)?

Onsite infusion therapy, centralized laboratory and pathology, an in-house specialty pharmacy, care coordination and financial counseling will remain available. According to American Oncology Network, these services continue to support treatment for cancer and blood disorders locally.

How does joining AONC affect access to clinical trials at Elkhart Hematology and Oncology (AONC)?

Joining AONC expands local access to clinical trials through the network’s resources and study portfolio. According to American Oncology Network, the affiliation aims to enhance trial availability while keeping treatment services and supportive care based in the community.